Cargando…
The importance of the dyad: Participant perspectives on sharing biomarker results in Alzheimer's disease research
BACKGROUND: In the asymptomatic “preclinical” phase of Alzheimer's disease (AD), abnormal biomarkers indicate risk for developing cognitive impairment. Biomarker information is increasingly being disclosed to participants in research settings, and biomarker testing and results disclosure will b...
Autores principales: | Ketchum, Fred B., Chin, Nathaniel A., Erickson, Claire, Lambrou, Nickolas H., Basche, Kristin, Gleason, Carey E., Clark, Lindsay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423755/ https://www.ncbi.nlm.nih.gov/pubmed/37583545 http://dx.doi.org/10.1002/trc2.12416 |
Ejemplares similares
-
What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer’s Disease Biomarker Research? A Qualitative Vignette Analysis
por: Ketchum, Fred B., et al.
Publicado: (2022) -
Anticipated reactions to learning Alzheimer’s disease biomarker results
por: Clark, Lindsay R., et al.
Publicado: (2022) -
Research Participant Interest in Alzheimer’s Disease Biomarker Disclosure
por: Erickson, Claire, et al.
Publicado: (2020) -
Predictors of positive or negative reactions to learning Alzheimer’s biomarker results
por: Erickson, Claire, et al.
Publicado: (2021) -
Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society
por: Erickson, Claire M., et al.
Publicado: (2022)